These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 150802)
1. Endocrine-induced regression of cancers. Huggins C Am J Surg; 1978 Aug; 136(2):233-8. PubMed ID: 150802 [No Abstract] [Full Text] [Related]
2. Current status of bilateral adrenalectomy or advanced prostatic carcinoma. Bhanalaph T; Varkarakis MJ; Murphy GP Ann Surg; 1974 Jan; 179(1):17-23. PubMed ID: 4817870 [No Abstract] [Full Text] [Related]
3. PROGNOSTICATION OF CARCINOMA OF THE PROSTATE METASTATIC TO THE SKELETON BY RADIOLOGICAL STUDIES. SCHIRMER HK; RICHARDS GJ J Urol; 1964 Dec; 92():714-20. PubMed ID: 14241206 [No Abstract] [Full Text] [Related]
7. Endocrine manipulation in the treatment of breast cancer. Segaloff A Clin Obstet Gynecol; 1975 Jun; 18(2):227-37. PubMed ID: 166781 [No Abstract] [Full Text] [Related]
9. [Hormones and tumor therapy: current clinical status and future developments in endocrine therapy of breast cancer]. Szepesi T; Schratter-Sehn AU Wien Klin Wochenschr; 1982 Sep; 94(17):463-9. PubMed ID: 6760557 [TBL] [Abstract][Full Text] [Related]
10. [ENDOCRINE TREATMENT OF ADVANCED MAMMARY CANCER]. JADRESIC A; PABST I; POBLETE M Rev Med Chil; 1964 Feb; 92():132-9. PubMed ID: 14165297 [No Abstract] [Full Text] [Related]
11. Endocrine therapy of breast cancer. McGuire WL Annu Rev Med; 1975; 26():353-63. PubMed ID: 167649 [No Abstract] [Full Text] [Related]
12. Lung metastases in prostatic carcinoma. Clinical significance. Varkarakis MJ; Winterberger AR; Gaeta J; Moore RH; Murphy GP Urology; 1974 Apr; 3(4):447-52. PubMed ID: 4856662 [No Abstract] [Full Text] [Related]
14. Selection of hormone-dependent breast cancers. Hobbs JR; De Souza I; Salih H; Raggatt P Br J Surg; 1974 Oct; 61(10):785-6. PubMed ID: 4370356 [No Abstract] [Full Text] [Related]
15. [Possibilities and limitations of endocrine therapy of metastasizing breast cancer]. Nowakowski H Verh Dtsch Ges Inn Med; 1967; 73():505-18. PubMed ID: 5591802 [No Abstract] [Full Text] [Related]
16. Management of reactivated prostatic cancer. Murphy G Vitam Horm; 1975; 33():399-415. PubMed ID: 779252 [No Abstract] [Full Text] [Related]
17. Predictability of response to endocrine ablation in breast cancer. Criss WE; Bland KI; O'Leary JP South Med J; 1975 Jun; 68(6):714-6. PubMed ID: 166448 [TBL] [Abstract][Full Text] [Related]
18. SURVIVAL OF WOMEN WITH HORMONALLY TREATED BREAST CANCER. GOLDENBERG IS; BAILAR JC; LOWRY R Surg Gynecol Obstet; 1964 Oct; 119():785-9. PubMed ID: 14211212 [No Abstract] [Full Text] [Related]
19. [Therapy of metastasizing breast carcinomas]. Martz G Schweiz Med Wochenschr; 1966 May; 96(19):638-9. PubMed ID: 5985856 [No Abstract] [Full Text] [Related]
20. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Huggins C; Hodges CV CA Cancer J Clin; 1972; 22(4):232-40. PubMed ID: 4625049 [No Abstract] [Full Text] [Related] [Next] [New Search]